Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-19 4:50 pm Purchase |
2022-05-09 | 13G | ImmunoGen, Inc. IMGN |
Flynn James E | 14,779,590 6.700% |
14,779,590 (New Position) |
Filing History |
| 2022-05-17 3:06 pm Sale |
2022-05-17 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 5,000,000 4.990% |
-5,000,000 (-50.00%) |
Filing History |
| 2022-05-11 1:50 pm Purchase |
2022-05-10 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Flynn James E | 1,324,214 5.040% |
1,324,214 (New Position) |
Filing History |
| 2022-05-10 5:26 pm Purchase |
2022-05-10 | 13G | PepGen Inc. PEPG |
Flynn James E | 953,626 4.260% |
953,626 (New Position) |
Filing History |
| 2022-05-03 5:11 pm Purchase |
2022-05-03 | 13G | HilleVax, Inc. HLVX |
Flynn James E | 2,617,948 7.830% |
2,617,948 (New Position) |
Filing History |
| 2022-04-27 3:49 pm Purchase |
2022-04-24 | 13D | Acutus Medical, Inc. AFIB |
Flynn James E | 5,864,514 9.400% |
11,590 (+0.20%) |
Filing History |
| 2022-02-11 4:37 pm Purchase |
2021-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Flynn James E | 2,344,786 9.910% |
1,194,487 (+103.84%) |
Filing History |
| 2022-02-11 4:22 pm Sale |
2021-12-31 | 13G | Itamar Medical Ltd. ITMR |
Flynn James E | 0 0.000% |
-23,814,090 (Position Closed) |
Filing History |
| 2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 0 0.000% |
-3,959,741 (Position Closed) |
Filing History |
| 2022-02-11 4:21 pm Sale |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Flynn James E | 0 0.000% |
-1,419,651 (Position Closed) |
Filing History |
| 2022-02-11 4:20 pm Purchase |
2021-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 5,882,353 4.500% |
5,882,353 (New Position) |
Filing History |
| 2022-02-11 4:19 pm Purchase |
2021-12-31 | 13G | Surrozen, Inc. SRZN |
Flynn James E | 11,111 0.470% |
11,111 (New Position) |
Filing History |
| 2022-02-11 4:19 pm Sale |
2021-12-31 | 13G | Beyond Air, Inc. XAIR |
Flynn James E | 833,334 3.030% |
-23,529 (-2.75%) |
Filing History |
| 2022-02-11 4:18 pm Sale |
2021-12-31 | 13G | Wave Life Sciences Ltd. WVE |
Flynn James E | 552,690 0.940% |
-3,357,740 (-85.87%) |
Filing History |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 1,125,083 2.590% |
-1,035,917 (-47.94%) |
Filing History |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
Flynn James E | 1,867,467 3.710% |
-853,736 (-31.37%) |
Filing History |
| 2022-02-11 4:16 pm Purchase |
2021-12-31 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 423,237 5.790% |
3,586 (+0.85%) |
Filing History |
| 2022-02-11 4:15 pm Sale |
2021-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,345,959 9.280% |
-36,074 (-1.51%) |
Filing History |
| 2022-02-11 4:14 pm Sale |
2021-12-31 | 13G | Xilio Therapeutics, Inc. XLO |
Flynn James E | 2,154,061 7.840% |
-133,883 (-5.85%) |
Filing History |
| 2022-02-11 4:14 pm Purchase |
2021-12-31 | 13G | Nuvalent, Inc. NUVL |
Flynn James E | 24,776,278 45.140% |
24,776,278 (New Position) |
Filing History |